Condition
Myotonic Muscular Dystrophy
Total Trials
4
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 3 (1)
Trial Status
Completed2
Active Not Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05027269Phase 1Completed
Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients
NCT06411288Phase 3Active Not Recruiting
Global Study of Del-desiran for the Treatment of DM1
NCT00082108Recruiting
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
NCT00004769CompletedPrimary
Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy
Showing all 4 trials